Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy
Author(s) -
Milesi,
Giovanni Guaraldi,
Gabriella Orlando,
Caterina Durante,
Marcello Pinti,
Elisa Nemes,
Giulia Nardini,
Giuseppe Passarino,
Marina Cocchi,
Roberto Esposito,
Cristina Mussini,
Andrea Cossarizza
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/591706
Subject(s) - haplogroup , lipodystrophy , human mitochondrial dna haplogroup , medicine , population , insulin resistance , mitochondrial dna , gastroenterology , haplotype , endocrinology , viral load , biology , obesity , immunology , genetics , genotype , antiretroviral therapy , human immunodeficiency virus (hiv) , environmental health , gene
The combination of different point mutations in mitochondrial DNA (mtDNA), which are defined as haplogroups, may cause modification in organelle function and may be involved in several pathologies. We analyzed the distribution of mtDNA polymorphisms in human immunodeficiency virus (HIV)-infected patients with lipodystrophy, a relevant adverse event caused by highly active antiretroviral therapy, and their correlation with metabolic and viroimmunologic parameters.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom